UOC
TEVA icon

UBS O'Connor’s Teva Pharmaceuticals TEVA Stock Holding History

UBS O'Connor’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-223,596
Closed -$3.75M – 483
2025
Q2 		$3.75M Buy
223,596
+122,808
+122% +$1.98M 0.1% 93
2025
Q1 		$1.55M Sell
100,788
-37,237
-27% -$665K 0.04% 146
2024
Q4 		$3.04M Buy
138,025
+58,893
+74% +$1.07M 0.08% 121
2024
Q3 		$1.43M Buy
79,132
+28,236
+55% +$494K 0.04% 232
2024
Q2 		$827K Buy
50,896
+6,000
+13% +$92.4K 0.02% 321
2024
Q1 		$633K Sell
44,896
-45,121
-50% -$569K 0.02% 317
2023
Q4 		$940K Sell
90,017
-94,983
-51% -$887K 0.03% 277
2023
Q3 		$1.89M Buy
+185,000
New +$1.72M 0.03% 254
2018
Q3 		– Sell
-22,000
Closed -$535K – 341
2018
Q2 		$535K Buy
+22,000
New +$449K 0.01% 232
2017
Q4 		– Sell
-40,000
Closed -$704K – 382
2017
Q3 		$704K Buy
+40,000
New +$900K 0.01% 299

Other funds holding TEVA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.5B AUM 68.34% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.04B AUM 91.14% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PC
PointState Capital New York $4.31B AUM 42.31% 1-Year Est. Return